Author:
Krishnan Rahul,Lamb Morgan,Alexander Michael,Chapman David,Imagawa David,Lakey Jonathan R. T.
Reference131 articles.
1. (CBER) CfBEaR (2003) Guidance for industry: source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humans. Food and Drug Administration.
http://www.fda.gov/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/xenotransplantation/ucm074354.htm#CLINICALISSUESINXENOTRANSPLANTATION
. Accessed 27 Aug 2013
2. Abalovich AG, Bacque MC, Grana D, Milei J (2009) Pig pancreatic islet transplantation into spontaneously diabetic dogs. Transplant Proc 41(1):328–330
3. Alexander EL, Dooley KC, Pohajdak B, Xu BY, Wright JR Jr (2006) Things we have learned from tilapia islet xenotransplantation. Gen Comp Endocrinol 148(2):125–131
4. Allan JS (1995) Xenograft transplantation of the infectious disease conundrum. ILAR J/Natl Res Counc Inst Lab Anim Resour 37(1):37–48
5. Anderson HR, Stitt AW, Gardiner TA, Lloyd SJ, Archer DB (1993) Induction of alloxan/streptozotocin diabetes in dogs: a revised experimental technique. Lab Anim 27(3):281–285